Qing Hao Bie Jia Tang (Artemisia Annua and Soft Shelled Turtle Shell Decoction)

Actions

Indications

Western Uses:

• What conditions is Qing Hao Bie Jia Tang used for in modern practice?

  Qing Hao Bie Jia Tang clears smouldering heat from yin deficiency in the late stage of a febrile illness (a night fever that abates by morning, with no sweating), so it is referenced for lingering low-grade fevers and chronic depleting conditions: consumptive fever (phthisis/tuberculosis), summer fever in children, chronic pyelonephritis, renal tuberculosis, chronic nephritis, and the advanced stages of various infectious diseases.

  It is chosen for the yin-deficient smouldering-heat pattern, not for a diagnosis. Tuberculosis (pulmonary or renal) is a serious, infectious, notifiable disease requiring medical treatment; a persistent fever always needs assessment. This formula is a traditional adjunct, not a substitute. Traditional-use correlates only, not a treatment claim.

  Source: Sacred Lotus sources & references (pattern) + Bensky & Barolet, Formulas & Strategies; biomedical correlates as reference only. Not medical advice.

Originally Appeared In:

• Systematic Differentiation of Warm Diseases (Wen Bing Tiao Bian)

Notes:

• How does Qing Hao Bie Jia Tang differ from Qing Gu San and Dang Gui Liu Huang Tang?

  All three formulas address heat associated with yin deficiency, but they are distinguished by the stage and specific character of that heat — and the fever-timing pattern is the key diagnostic differentiator.

  • vs Qing Gu San (Clear the Bone Powder): Qing Gu San treats chronic “steaming bone” (gu zheng) yin-deficiency heat generally, without the specific late-warm-disease context or the night-fever/morning-clear-without-sweat timing that marks Qing Hao Bie Jia Tang; it is built around a broader set of bone/yin-cooling herbs rather than the Qing Hao/Bie Jia venting pair.
  • vs Dang Gui Liu Huang Tang: that formula treats yin-deficiency fire specifically presenting with night sweats — heat forcing its way out through sweating as yin fails to contain yang at night. Qing Hao Bie Jia Tang’s fever, by contrast, recedes toward morning without sweating, indicating the heat is still lodged/hidden in the yin level rather than being expelled through the pores — a different mechanism calling for a heat-leading, not sweat-restraining, strategy.

  Classical source: Wen Bing Tiao Bian (Systematic Differentiation of Warm-Heat Diseases), by Wu Ju-tong (Wu Tang), 1798 CE — a foundational text of the Wen Bing (warm-disease) school, in the section addressing residual heat remaining in the yin level in the aftermath of an acute febrile illness.

  Note on excess-vs-deficiency heat mimicry: as with several yin-deficiency-fever formulas, the pattern here can superficially resemble an ongoing excess-heat illness; the absence of sweating with the fever, the red-but-scanty-coated tongue, and the thin rapid (rather than full, forceful) pulse are the differentiating signs pointing to lingering yin-level heat rather than active excess heat.

  Source: Bensky & Barolet, Formulas & Strategies; Chen & Chen, Chinese Herbal Formulas and Applications (classical source, formula comparisons).

Clinical Studies & Research:

• Is there modern research on Qing Hao Bie Jia Tang?

  Yes — modern research on Qinghao Biejia Decoction (QBD) spans network-pharmacology/mechanistic studies and a body of clinical research, though much of the clinical work has been applied to conditions well outside the formula’s classical late-warm-disease indication, most notably systemic lupus erythematosus (SLE). This reflects modern TCM practice matching the formula to any presentation showing a similar yin-deficiency-heat pattern, rather than new evidence for its original indication specifically.

  • Systemic lupus erythematosus (meta-analysis of 9 RCTs, 655 participants): QBD added to conventional medication improved overall response rate and reduced SLE disease-activity and TCM symptom scores compared with conventional medication alone (PMID 34421590).
  • Cancer-related fever (literature review and case report, 2026): traces QBD’s classical “latent heat in the yin” theory forward to its use, often modified, for fever associated with lung cancer, and reports one clinical case (PMID 41797778).
  • Perimenopausal insomnia (randomized controlled trial, n=160): QBD combined with auricular acupoint seed embedding improved sleep-quality measures and TCM syndrome scores more than either therapy alone or education-only control (PMID 42021579).
  • Chronic liver disease (network pharmacology): computational modeling proposed MAPK and PI3K/AKT signaling pathways as candidate mechanisms for QBD’s anti-inflammatory and anti-tumor properties in a liver-disease context (PMID 36277879).

  Sources: PubMed 34421590; PubMed 41797778; PubMed 42021579; PubMed 36277879. Research context, not a therapeutic claim; the SLE and insomnia trials are clinical but for conditions distinct from the formula’s classical indication, and the liver-disease work is computational/mechanistic (network pharmacology), not clinical evidence.